Dense-Pac expands into 3-D x-ray market

Article

Dense-Pac, a company specializing in proprietary high-density packaging of computer memory, announced that its technology will be used in high-definition x-ray equipment that can produce three-dimensional images with real-time applications.Dense-Pac

Dense-Pac, a company specializing in proprietary high-density packaging of computer memory, announced that its technology will be used in high-definition x-ray equipment that can produce three-dimensional images with real-time applications.

Dense-Pac Microsystems of Garden Grove, CA, develops products that allow commercial, industrial, defense, and aerospace customers to pack large amounts of memory into small spaces. Its commercial products include applications such as network servers, computer storage devices, and medical instrumentation.

“Our goal for this year is to continue our penetration of the workstation and server market while concurrently expanding our technology into new vertical industries,” said Ted Bruce, Dense-Pac’s president and CEO. “The medical instrumentation field is just one vertical we have targeted for expansion.”

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.